Form EFFECT Lyra Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 26, 2026 |
| Accession Number: | 0001193125-26-124474 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ballard Power announces results of 2026 Annual General Meeting of Shareholders
- Colombian Pharmaceutical Distributor Cuts Drugstore Procurement Costs by 50% Using Its Own In-House AI Engine – Now Serving 6,000+ Pharmacies Across Latin America
- Pimsy Just Went Live: The Digital Being Gen Z and Gen Alpha Already Follow
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
